#44: zantriocom: Zantrio.com Free Daily Stock Picks 10-8-09
(SVNT) - shortSavient Pharma announced 4 million share common stock offering... |
October 8, 2009
08:30:40 AM |
#43: zantriocom: Zantrio.com Stock Picks for June 17, 2009
(SVNT) - buySavient Pharmaceuticals received a vote of 14 to 1 today by the FDA... |
June 17, 2009
08:58:54 AM |
#42: TheMachine: Pharmaceutical Stock News : SVNT Stock News : Savient to Present Multiple Abstracts At the European League Against Rheumatism (EULAR) 2009 Annual Congress
EAST BRUNSWICK, N.J., May 29, 2009 (GLOBE NEWSWIRE) -- Savient
Pharmaceuticals,... |
June 11, 2009
02:15:33 AM |
#41: TheMachine: Savient Pharmaceuticals Reports Second Quarter 2008 Financial Results
Conference Call Scheduled for August 7, 2008 at 10:00 a.m. EDT
... |
September 20, 2008
01:19:39 AM |
#40: TheMachine: Savient Announces U.S. Court of Appeals Affirmation of the Dismissal of Securities Class Action Complaint
Savient Pharmaceuticals, Inc. (NASDAQ:SVNT) today announced that the... |
July 19, 2008
01:47:35 AM |
#39: TheMachine: Savient Provides Update On Puricase(R) (pegloticase) Biologics License Application
Savient Pharmaceuticals, Inc. (NASDAQ:SVNT) today announced an update... |
May 7, 2008
11:29:33 AM |
#38: TheMachine: Savient Pharmaceuticals to Present at 28th Annual Cowen Healthcare Conference on March 18
Savient Pharmaceuticals, Inc. (NASDAQ:SVNT) today announced that Paul... |
April 16, 2008
12:41:53 AM |
#37: Stock News Bot: Puricase(R) (pegloticase) Meets Pre-Specified Primary Efficacy Endpoint in Two Replicate Phase 3 Studies
Pooled Analysis of Secondary Endpoints Shows Statistical Significance in the... |
December 13, 2007
10:10:26 AM |
#36: Stock News Bot: SVNT News Savient Pharmaceuticals Reports Fourth Quarter and Year End 2006 Results
EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Savient Pharmaceuticals, Inc. (NASDAQ:SVNT)... |
March 13, 2007
02:46:00 PM |
#35: Stock News Bot: SVNT News Savient Pharmaceuticals to Hold Fourth Quarter and Year End Financial Results Conference Call on Wednesday, March 14, 2007
EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Savient Pharmaceuticals, Inc. (NASDAQ:SVNT)... |
March 7, 2007
06:24:00 AM |
#34: Stock News Bot: SVNT News Savient Announces Completion of Patient Enrollment in Phase 3 Trials of Puricase(R) for Treatment-Failure Gout
EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Savient Pharmaceuticals, Inc. (NASDAQ:SVNT)... |
March 6, 2007
09:43:00 AM |
#33: Stock News Bot: SVNT News Savient Pharmaceuticals Restructures Commercial Operations Following Launch of Authorized Generic
EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Savient Pharmaceuticals, Inc. (NASDAQ:SVNT)... |
January 5, 2007
01:51:00 PM |
#32: Stock News Bot: SVNT News Savient Pharmaceuticals Announces Launch of Authorized Generic of Oxandrin(R) with Watson Pharmaceuticals
EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Savient Pharmaceuticals, Inc. (NASDAQ:SVNT)... |
December 29, 2006
06:25:00 AM |
#31: Stock News Bot: SVNT News Savient Pharmaceuticals Announces Appellate Court Decision in Patent Infringement Lawsuit against Sandoz Pharmaceuticals and Upsher-Smith Laboratories
EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Savient Pharmaceuticals, Inc. (NASDAQ:SVNT)... |
December 12, 2006
03:52:00 PM |
#30: Stock News Bot: SVNT News Savient Pharmaceuticals Announces Modification of Temporary Restraining Order in Patent Infringement Lawsuit against Sandoz Pharmaceuticals and Upsher-Smith Laboratories
EAST BRUNSWICK, N.J.--(BUSINESS WIRE)--Savient Pharmaceuticals, Inc. (NASDAQ:... |
December 11, 2006
06:30:00 AM |
